U.S. Auto Stock News

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Nektar Therapeutics ( NASDAQ:NKTR ) shareholders that were waiting for something to happen have been dealt a blow with...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

For many, the main point of investing in the stock market is to achieve spectacular returns. When you find (and hold) a...

In December 2025, Elastic N.V. announced it would partner with the U.S. Cybersecurity and Infrastructure Security Agency (CISA) and ECS to build a unified SIEM-as-a-Service platform for federal civilian agencies on its FedRAMP-certified Elastic Cloud, under a base-year US$26 million contract that could reach up to US$130 million by 2030. This collaboration deepens Elastic's role in U.S. federal cybersecurity by standardizing large-scale threat detection and incident response across agencies...

Earlier this year, Brown & Brown reported third-quarter 2025 results that surpassed market expectations, with revenue rising 35.4% year on year and non-GAAP earnings per share beating analyst estimates by 12.9%. The outperformance was driven largely by acquisitions and profit-sharing contingent commissions, highlighting how Brown & Brown’s expansion efforts are feeding directly into stronger top- and bottom-line results. With Brown & Brown’s recent earnings beat underpinned by...

Dell Technologies recently tightened its return-to-office rules for North American commercial sales staff, requiring them to work in the office five days a week for at least eight hours a day after internal reviews showed uneven compliance with earlier policies. At the same time, Dell’s evolution into an AI infrastructure provider with a large AI server order backlog and a long-term revenue growth outlook has drawn fresh attention to how its culture and operations support this shift. Next,...

Earlier this year, Camtek reported its strongest quarter on record, with third‑quarter revenue lifted by demand for AI‑related advanced packaging inspection tools. At the same time, First Wilshire Securities Management cut its position by 81,598 shares, even as Camtek’s margins expanded and its balance sheet remained strong. We’ll now examine how Camtek’s record AI‑driven advanced packaging revenue shapes the company’s broader investment narrative and future prospects. These 12 companies...

DXP Enterprises (DXPE) just gave investors a fresh catalyst by closing a major refinancing of its Senior Secured Term Loan B and adding $205 million in new borrowings to fuel acquisition led growth. See our latest analysis for DXP Enterprises. The refinancing headlines arrive as DXP’s share price sits at $115.0, with a strong year to date share price return of 36 percent and a powerful five year total shareholder return of roughly 406 percent, signaling that momentum around its acquisition...

Stride (LRN) is back in the spotlight after a wave of class action lawsuits accused the online education company of inflating enrollment with ghost students and cutting corners on key compliance obligations. See our latest analysis for Stride. The wave of legal actions has clearly reset expectations, with a roughly 55 percent 3 month share price return collapse and a much weaker 1 year total shareholder return, even after a modest recent bounce toward 65.95 dollars as the market reassesses...

Rockwell Automation (ROK) is back on investors radar after highlighting fresh progress in AI driven autonomous operations, alongside releasing its 2025 Sustainability Report, a combination that neatly ties growth, efficiency, and long term risk management. See our latest analysis for Rockwell Automation. Those AI and sustainability updates are landing at a time when momentum is clearly building, with Rockwell Automation’s share price up 17.11% over 90 days and a 41.77% year to date share...

Sirius XM Holdings (SIRI) is back in the spotlight after renewing Howard Stern for another multi year run, a move that shores up a core content pillar and underpins subscriber stability. See our latest analysis for Sirius XM Holdings. Shares have cooled off lately, with the 90 day share price return down 7.6 percent, even as Berkshire Hathaway’s larger stake, rising short interest and expectations for a 2026 revenue rebound keep the long term story very much alive. If Stern’s renewal has you...

Cadre Holdings’ subsidiary Med-Eng LLC previously secured a five-year, US$50,000,000 contract with the US Department of Defense to supply blast‑exposure monitoring systems for tracking overpressure events in combat and training settings, with first deliveries planned for 2026. This award deepens Cadre’s ties with the Pentagon and highlights its growing role in advanced protective technologies that support frontline military personnel. We’ll now examine how this multi‑year Pentagon contract...

Earlier this year, Vertex authorized its first-ever US$150,000,000 share repurchase program and ended the quarter with more than US$313,000,000 in cash, while New York City-based Hyperion Capital Advisors initiated a new 540,000-share stake representing 7.16% of its reported U.S. equity assets. Taken together, the buyback authorization and fresh institutional interest highlight management’s confidence in Vertex’s balance sheet strength and long-term business outlook. Now, we’ll explore how...

In December 2025, Marriott International reported that it had reached 100 signed agreements for City Express by Marriott properties across the U.S. and Canada, while Trinity Hills Valley, S.A. announced a franchise deal to bring a Tribute Portfolio hotel and residences to a new surf lagoon-anchored resort in Panama. Together, these moves highlight Marriott’s push into midscale and experiential offerings to attract value-focused guests and expand its global footprint. We’ll now examine how...

Brookfield Infrastructure Partners Stock: Why Investors Are Paying Attention Brookfield Infrastructure Partners (NYSE:BIP) has quietly outperformed the broader market over the past year, and that steady climb has some income focused investors revisiting the partnership’s mix of yield, growth, and global assets. See our latest analysis for Brookfield Infrastructure Partners. After a solid run this year, with a roughly 10 percent year to date share price return and a 15 percent one year total...

Greenbrier Companies (GBX) has quietly turned in a mixed stretch, with shares up about 7% over the past month but still down roughly 24% this year, leaving value focused investors taking a closer look. See our latest analysis for Greenbrier Companies. The recent 1 month share price return of 7.37% suggests some momentum is returning. However, the year to date share price return of negative 24.02 percent and a 1 year total shareholder return of negative 24.03 percent show investors are still...

UDR (UDR) just expanded its joint venture with LaSalle Investment Management by $230 million, adding four apartment communities and pushing the portfolio to 2,564 homes, a scale and diversification shift investors cannot ignore. See our latest analysis for UDR. The joint venture expansion, alongside UDR’s freshly affirmed quarterly dividend, has helped steady sentiment. Yet the share price return is still negative year to date, while multi year total shareholder returns remain modestly...

In December 2025, ACADIA Pharmaceuticals reported that the FDA had approved DAYBUE STIX, a dye- and preservative-free powder formulation of trofinetide, for treating Rett syndrome in patients aged two and older, based on bioequivalence to the existing oral solution. This new formulation, expected to launch in limited quantities in early 2026 while the original oral solution remains available, broadens dosing flexibility and taste options that could be important for long-term treatment...

Emerson Electric (EMR) is back in focus as investors connect its industrial IoT and automation portfolio with accelerating demand for smarter cold chain monitoring across pharmaceuticals, biologics, and perishable foods, where reliability and compliance really matter. See our latest analysis for Emerson Electric. That backdrop helps explain why investors have kept bidding Emerson higher, with an 11.6% year to date share price return and a robust 5 year total shareholder return near 90%,...

Blackbaud (BLKB) has quietly put up a mixed scorecard for shareholders, with the stock up about 15 % over the past month but still down roughly 17 % over the past year. See our latest analysis for Blackbaud. That sharp 30 day share price return of about 15 % looks more like a short term reset than a full trend change. This is especially the case with the year long total shareholder return still clearly negative and the longer term record only modestly positive. If Blackbaud has you watching...

GXO Logistics has announced a series of leadership changes, including appointing Karen Bomber as Chief Commercial Officer and Bart Beeks as Chief Operating Officer effective in early 2026, alongside a transition from Brad Jacobs to Patrick Byrne as Non-Executive Chairman after December 31, 2025. Together, these shifts signal an intensified emphasis on commercial excellence and global operational discipline as GXO integrates Wincanton and refines its go-to-market approach. We’ll now examine...

Driven Brands Holdings (DRVN) just added veteran retail finance executive Timothy Johnson to its Board and Audit Committee, a governance move that lands as the company wrestles with weak returns and frustrated shareholders. See our latest analysis for Driven Brands Holdings. Those governance tweaks are arriving after a choppy stretch for investors, with a roughly 5.6% one month share price return at $14.91 failing to offset a weak one year total shareholder return and a deeply negative three...

Dianthus Therapeutics (DNTH) just cleared an important milestone by dosing the first subject in a Phase 1 trial of LBL-047 (DNTH212), a bifunctional fusion protein aimed at tough autoimmune disorders like systemic lupus erythematosus. See our latest analysis for Dianthus Therapeutics. The market seems to be warming to that story, with the latest closing share price at $43.15 and a 90 day share price return of 20.4 percent, while the 1 year total shareholder return of 88.4 percent points to...